Efficacy and Adverse Events of Apatinib Salvage Treatment for Refractory Diffuse Malignant Peritoneal Mesothelioma: A Pilot Study

OBJECTIVE: To investigate the clinical efficacy and adverse events (AEs) of apatinib salvage treatment for diffuse malignant peritoneal mesothelioma (DMPM) that has failed to respond to the recommended treatments. METHODS: 27 patients with refractory DMPM were treated with apatinib at our center fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhi-Ran, Su, Yan-Dong, Ma, Ru, Wu, He-Liang, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283831/
https://www.ncbi.nlm.nih.gov/pubmed/35847956
http://dx.doi.org/10.3389/fonc.2022.811800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283831/
https://www.ncbi.nlm.nih.gov/pubmed/35847956
http://dx.doi.org/10.3389/fonc.2022.811800

Ejemplares similares